For the year ending 2025-12-31, PAMT had -$32,826K decrease in cash & cash equivalents over the period. -$23,405K in free cash flow.
| Cash Flow | 2025-12-31 |
|---|---|
| Net (loss) income | -52,607 |
| Depreciation | 83,298 |
| Impairment loss | 0 |
| Bad debt expense | 1,779 |
| Stock compensationnet of excess tax benefits | 548 |
| Provision for deferred income tax (benefit) expense | -18,858 |
| Recognized (gain) on marketable equity securities | 6,671 |
| (gain) loss on sale or disposal of equipment | 15,474 |
| Accounts receivable | -9,402 |
| Prepaid expenses, deposits, inventories, and other assets | -1,831 |
| Income taxes refundable | -549 |
| Income taxes payable | 0 |
| Trade accounts payable | -11,565 |
| Accrued expenses and other liabilities | 25,103 |
| Net cash provided by operating activities | 17,335 |
| Purchases of property and equipment | 40,740 |
| Proceeds from disposition of equipment | 58,334 |
| Sales of marketable equity securities | 5,040 |
| Purchases of marketable equity securities, net of return of capital | 4,237 |
| Net cash provided by (used in) investing activities | 18,397 |
| Borrowings under line of credit | 651,649 |
| Repayments under line of credit | 651,649 |
| Borrowings of long-term debt | 30,000 |
| Repayments of long-term debt | 83,630 |
| Borrowings under margin account | 1,807 |
| Repayments under margin account | 1,807 |
| Repurchases of treasury stock | 14,928 |
| Proceeds from exercise of stock options | 0 |
| Net cash (used) provided by financing activities | -68,558 |
| Net (decrease) increase in cash and cash equivalents | -32,826 |
| Cash and cash equivalentsbeginning of year | 68,060 |
| Cash and cash equivalentsend of year | 35,234 |
PAMT CORP (PAMT)
PAMT CORP (PAMT)